| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE
|
angiotensin I converting enzyme
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AIMP1
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AMPH
|
amphiphysin
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ATF1
|
activating transcription factor 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATN1
|
atrophin 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BLNK
|
B-cell linker
|
|
BMF
|
Bcl2 modifying factor
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CAV2
|
caveolin 2
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC25C
|
cell division cycle 25C
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
DAXX
|
death-domain associated protein
|
|
DBNL
|
drebrin-like
|
|
DCP1A
|
decapping mRNA 1A
|
|
DCX
|
doublecortin
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DOCK7
|
dedicator of cytokinesis 7
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DUSP8
|
dual specificity phosphatase 8
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4ENIF1
|
eukaryotic translation initiation factor 4E nuclear import factor 1
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EP300
|
E1A binding protein p300
|
|
EPHB1
|
EPH receptor B1
|
|
ESR1
|
estrogen receptor 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FUS
|
FUS RNA binding protein
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H2AFX
|
H2A histone family, member X
|
|
H3F3A
|
H3 histone, family 3A
|
|
H3F3B
|
H3 histone, family 3B (H3.3B)
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
IER3
|
immediate early response 3
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
INSR
|
insulin receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
JDP2
|
Jun dimerization protein 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLC1
|
kinesin light chain 1
|
|
KRT8
|
keratin 8, type II
|
|
LMTK1
|
lemur tail kinase 1
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K6
|
mitogen-activated protein kinase kinase kinase 6
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K9
|
mitogen-activated protein kinase kinase kinase 9
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK15
|
mitogen-activated protein kinase 15
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYOD1
|
myogenic differentiation 1
|
|
NACA
|
nascent polypeptide-associated complex alpha subunit
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRL
|
neural retina leucine zipper
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PNPLA8
|
patatin-like phospholipase domain containing 8
|
|
PPM1J
|
protein phosphatase, Mg2+/Mn2+ dependent, 1J
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKD1
|
protein kinase D1
|
|
PRL
|
prolactin
|
|
PSEN1
|
presenilin 1
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7
|
|
PXN
|
paxillin
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RCSD1
|
RCSD domain containing 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRN3
|
RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae)
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SFN
|
stratifin
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SH2D3A
|
SH2 domain containing 3A
|
|
SH2D3C
|
SH2 domain containing 3C
|
|
SH3BP5
|
SH3-domain binding protein 5 (BTK-associated)
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SLK
|
STE20-like kinase
|
|
SP1
|
Sp1 transcription factor
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK3
|
serine/threonine kinase 3
|
|
STK4
|
serine/threonine kinase 4
|
|
STMN1
|
stathmin 1
|
|
STMN2
|
stathmin 2
|
|
SYT4
|
synaptotagmin IV
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3
|
|
TAOK2
|
TAO kinase 2
|
|
TP53
|
tumor protein p53
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
UBXN1
|
UBX domain protein 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
